“This paper introduces the research progress in the field of treatment of diabetes nephropathy (DKD). Experts have explored the subject of flavonoids targeting inhibition of TGF - β/Smad signaling pathway to intervene in DKD, which provides a scientific basis for clinical prevention and development of targeted drugs for DKD.”